Since 2004, MSF has been delivering comprehensive HIV care in Dawei, including outreach initiatives aimed at preventing infection among marginalized and high-risk groups such as migrant workers, fishers and people who inject drugs. Despite the political instability affecting Myanmar, our activities have persisted over the years.
After two decades, of HIV work in Dawei, MSF is be transitioning its entire HIV patient cohort to the National AIDS Programme (NAP), reallocating its resources to support this program. Nevertheless, many of the challenges resulting from the collapse of the public healthcare system in 2021, which delayed the handover, still remain. It is a moment to reflect in pictures on twenty years of MSF's dedicated involvement in the fight against HIV in the region.
Caring for patients and tackling stigma
Dawei is a good example of the importance of MSF's commitment towards HIV patients in Myanmar. In 2004, the organisation decided to launch an intervention in response to the dual epidemic of HIV and tuberculosis, mainly affecting marginalized and vulnerable communities. Faced with the state's limited health capacities, MSF's action rapidly expanded.
Over the years, the Dawei project supported people living with HIV in many ways, from testing, treatment to peer-to-peer support about how to manage the disease and handle the stigmatisation that many patients feel.
Reaching rural communities
During its twenty years of work with people living with HIV in Dawei, MSF has continuously played an important role, adapting both to changing environments and to the needs of patients. MSF also significantly invested in reaching rural communities far from health centers, emphasizing prevention and, where necessary, providing adequate care.
In 2014, for the first time in Myanmar, patients began receiving oral treatment for Cytomegalovirus retinitis (CMVR), a neglected opportunistic disease linked to HIV/AIDS causing blindness. Previously the only treatment option available in Myanmar was painful once-weekly injections directly into the eye.